drugset / Trial / NCT02183493
Bioavailability of BI 1356 Administered With and Without Food to Healthy Male and Female Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
To investigate the food effect on the relative bioavailability and pharmacokinetics of a 5 mg BI 1356 tablet administered as a single dose
Timeline
- Start
- 2008-10
- Primary completion
- 2008-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linagliptin | Small molecule | 5 mg | — |
Indications
No indication recorded.